ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2012

The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.

Jason P Twohig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.